Sangamo Therapeutics, Inc.SGMONASDAQ
LOADING
|||
Cash Flow Performance
Trending higher, above historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-32.76%
↑ 21% above average
Average (9y)
-41.31%
Historical baseline
Range
High:7.40%
Low:-259.56%
CAGR
+21.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -32.76% | +87.4% |
| 2023 | -259.56% | -416.0% |
| 2022 | -50.30% | -112.6% |
| 2021 | -23.66% | -419.9% |
| 2020 | 7.40% | +142.0% |
| 2019 | -17.59% | -3210.9% |
| 2018 | -0.53% | -191.6% |
| 2017 | 0.58% | +101.9% |
| 2016 | -30.96% | -445.7% |
| 2015 | -5.67% | - |